新型冠状病毒感染大流行中风湿病共病患者的管理和疫苗接种特点
- 作者: Belyaeva I.B.1,2, Mazurov V.I.1,2, Sarantseva L.E.1,2, Trofimov E.A.1
-
隶属关系:
- North-Western State Medical University named after I.I. Mechnikov
- Сlinical Rheumatology Hospital No. 25
- 期: 卷 25, 编号 3 (2021)
- 页面: 17-26
- 栏目: Review
- URL: https://ogarev-online.ru/RFD/article/view/75815
- DOI: https://doi.org/10.17816/RFD75815
- ID: 75815
如何引用文章
详细
本文综述了一种新型冠状病毒感染(COVID-19)在免疫性风湿性疾病患者中的科学研究结果。在既定因素加剧其病程的情况下,这类患者感染冠状病毒的风险可能略高于人群风险(老年、肥胖、糖尿病、心血管疾病)。接受免疫抑制治疗和高剂量糖皮质激素的患者,可能会经历较长时间的阳性病毒复制和活病毒分离,因此需要动态监测和纠正抗风湿治疗。角膜后关节综合征可发生在病毒后关节炎的框架内,或首次出现免疫炎症性风湿病。文章介绍了全俄罗斯公共组织《俄罗斯风湿病学家协会》(«The Association of Rheumatologists of Russia»)的建议草案和The V.A. Nasonova Research Institute of Rheumatology关于COVID-19大流行条件下风湿病患者管理和疫苗接种的临时建议。
关键词
作者简介
Irina Belyaeva
North-Western State Medical University named after I.I. Mechnikov; Сlinical Rheumatology Hospital No. 25
Email: belib@mail.ru
ORCID iD: 0000-0002-7981-6349
SPIN 代码: 3136-9062
MD, Dr. Sci. (Med.), Assistant Professor
俄罗斯联邦, 41 Kirochnaya str., Saint Petersburg, 191015; Saint PetersburgVadim Mazurov
North-Western State Medical University named after I.I. Mechnikov; Сlinical Rheumatology Hospital No. 25
Email: maz.nwgmu@yandex.ru
ORCID iD: 0000-0002-0797-2051
SPIN 代码: 6823-5482
Scopus 作者 ID: 16936315400
Researcher ID: J-9643-2014
MD, Dr. Sci. (Med.), Professor, Honoured Science Worker, Academician of the RAS
俄罗斯联邦, 41 Kirochnaya str., Saint Petersburg, 191015; Saint PetersburgLyubov Sarantseva
North-Western State Medical University named after I.I. Mechnikov; Сlinical Rheumatology Hospital No. 25
Email: dr.liubovs@gmail.com
俄罗斯联邦, 41 Kirochnaya str., Saint Petersburg, 191015; Saint Petersburg
Evgeny Trofimov
North-Western State Medical University named after I.I. Mechnikov
编辑信件的主要联系方式.
Email: evgeniy.trofimov@szgmu.ru
SPIN 代码: 4358-1663
MD, Cand. Sci. (Med.), Assistant Professor
俄罗斯联邦, 41 Kirochnaya str., Saint Petersburg, 191015参考
- Belov BS, Muravyova NV, Tarasova GM. COVID-19: Rheumatological aspects. Effective pharmacotherapy. 2020;16(16):18–25. doi: 10.33978/2307-3586-2020-16-16-18-25
- Nasonov EL. Rossiiskie klinicheskie rekomendatsii. Revmatologiya. Moscow; 2018. P. 113–141. (In Russ.)
- Richman DD, Whitley RJ, Hayden FG. Clinical Virology, 4th ed. Washington: ASM Press; 2016.
- Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology. 2003;8 Suppl(Suppl 1):S9–14. doi: 10.1046/j.1440-1843.2003.00518.x
- Middle East Respiratory Syndrome Coronavirus [Internet]. Available from: https://www.who.int/emergencies/mers-cov/en/. Accessed: Feb 16, 2020.
- Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. J Med Virol. 2020;92(4):401–402. doi: 10.1002/jmv.25678
- Coronavirus disease 2019 (COVID-19) Situation Report–52 [Internet]. WHO. Available from: https://www.who.int/docs/default-source/coronaviruse/20200312-sitrep-52-covid-19.pdf?sfvrsn=e2bfc9c0_2. Accessed: Sep 11, 2021.
- Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574. doi: 10.1016/S0140-6736(20)30251-8
- Coronavirus disease (COVID-2019) situation reports. 2020 [Internet]. WHO. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed: Mar 5, 2020.
- Gorbalenya AE, Baker SC, Baric RS, et al. Severe acute respiratory syndrome-related coronaviruses: the species and its virus – a statement of the Coronavirus Study Group. bioRvxiv. 2020. doi: 10.1101/2020.02.07.937862
- Joo YB, Lim YH, Kim KJ, et al. Respiratory viral infections and the risk of rheumatoid arthritis. Arthritis Res Ther. 2019;21(1):199. doi: 10.1186/s13075-019-1977-9
- Li G, Fan Y, Lai Y, et al. Coronavirus infections and immune responses. J Med Virol. 2020;92(4):424–432. doi: 10.1002/jmv.25685
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5
- Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846–848. doi: 10.1007/s00134-020-05991-x
- Monti S, Balduzzi S, Delvino P, et al. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann. Rheum. Dis. 2020;79(5):667–668. doi: 10.1136/annrheumdis-2020-217424
- Tomelleri A, Sartorelli S, Campochiaro C, et al. Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey. Ann Rheum Dis. 2020;79(9):1252–1253. doi: 10.1136/annrheumdis-2020-217600
- Del Manso M, Andrianou X, Urdiales AM, et al. Integrated surveillance of COVID-19 in Italy outputs and related activities. Epidemiol Prev. 2020;44(5–6 Suppl 2):70–80. (In Italian). doi: 10.19191/EP20.5-6.S2.105
- Polyanskaya MV. Pnevmoniya u patsientov s revmaticheskimi zabolevaniyami: chastota vstrechaemosti, klinicheskaya kartina, faktory riska [disseretation]. Moscow; 2009. (In Russ.)
- Karateev AE, Amirdzhanova VN, Nasonov EL, et al. “Post-COVID syndrome”: The focus is on musculoskeletal pain. Rheumatology Science and Practice. 2021;59(3):255–262. (In Russ.). doi: 10.47360/1995-4484-2021-255-262
- Mazurov VI, Belyaeva IB, Sarantseva LE, et al. Impact of a new coronavirus infection on the clinical course of immunoinflammatory rheumatic diseases. North-West State Medical University named after I.I. Mechnikov. 2021;13(2):39–47. (In Russ.). doi: 10.17816/mechnikov72269
- Gasparotto M, Framba V, Piovella C, et al. Post-COVID-19 arthritis: a case report and literature review. Clin Rheumatol. 2021;40(8):3357–3362. doi: 10.1007/s10067-020-05550-1
- Derksen VFAM, Kissel T, Lamers-Karnebeek FBG, et al. Onset of rheumatoid arthritis after COVID-19: coincidence or connected? Ann Rheum Dis. 2021;annrheumdis-2021-219859. doi: 10.1136/annrheumdis-2021-219859
- Fragata I, Mourão AF. Coronavirus Disease 19 (COVID-19) complicated with post-viral arthritis. Acta Reumatol Port. 2020;45(4):278–280.
- Nasonov EL, Lila AM, Mazurov VI, et al. Koronavirusnaya bolezn’ 2019 (COVID-19) i immunovospalitel’nye (autoimmunnye) revmaticheskie zabolevaniya. Proekt rekomendatsii Obshcherossiiskoi obshchestvennoi organizatsii “Assotsiatsiya revmatologov Rossii” [Internet]. (In Russ.). Available from: https://rheumatolog.su/news/koronavirusnaya-bolezn-2019-COVID-19-i-immunovospalitelnye-autoimmunnye-revmaticheskie-zabolevaniya/. Accessed: Sep 25, 2021.
- O vaktsinatsii protiv SOVID-19 pri immunovospalitel’nykh revmaticheskikh zabolevaniyakh [Internet]. (In Russ.). Available from: https://rheumatolog.su/news/o-vakcinacii-protiv-sOVID-19-pri-immunovospalitelnyh-revmaticheskih-zabolevaniyah/. Accessed: Sep 25, 2021.
补充文件
